Sutent Sunitinib Capsules (12.5 mg, 25 mg, 50 mg)

At a Glance

Generic Name: Sunitinib (sunitinib malate)

Brand Name: Sutent

Strength & Pack Size: 12.5 mg (1 pack / 7 caps), 25 mg (1 pack / 7 caps), 50 mg (1 pack / 28 caps, EG)

Dosage Form & Route: Oral capsule, swallowed whole with water

Therapeutic Class: Multi-targeted tyrosine kinase inhibitor (TKI), VEGFR and PDGFR inhibitor (targeted anticancer therapy)

Primary Indications: Metastatic renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) after prior therapy, pancreatic neuroendocrine tumors (pNET) in appropriate patients

Usual Adult Dose: Defined by an oncologist based on indication, treatment goals, and tolerability

Prescription Status: Prescription-only medicine

Storage: Store in original packaging as directed on the label; protect from moisture and keep out of reach of children

Product Description

Sutent contains sunitinib, an oral targeted anticancer medicine used in specialist-led treatment plans for metastatic renal cell carcinoma, gastrointestinal stromal tumor, and pancreatic neuroendocrine tumors when an oncologist confirms that sunitinib therapy is appropriate. Sutent sunitinib capsules are offered in multiple strengths to support individualized dosing and monitoring, including 12.5 mg and 25 mg packs (1 pack / 7 caps) and a 50 mg pack (1 pack / 28 caps, EG). If you plan to buy Sutent online, make sure your diagnosis, intended treatment cycle, and monitoring schedule are confirmed by your cancer care team.

Sunitinib is widely referenced as a VEGFR-targeted TKI that can help control tumor growth by reducing signaling involved in tumor blood vessel formation and tumor cell proliferation. Because patient factors vary, your oncologist considers prior therapies, liver and kidney function, blood pressure history, heart risk, bleeding risk, and potential drug interactions before prescribing Sutent. Patients and caregivers managing a prescription-led oncology plan often search for this treatment as Sutent sunitinib capsules online when coordinating refills and maintaining continuity of care, especially when comparing options by sunitinib price and pack size.

Generic Meds Mart supplies Sutent in original packaging sourced through licensed channels. Packs are labeled for verification with the product name, active ingredient, strength, batch number, and expiry date so clinics and pharmacies can confirm authenticity on receipt. Orders are shipped in discreet outer packaging to support privacy, and worldwide delivery options help patients plan access alongside regular monitoring.

Key Uses

Sutent (sunitinib) is used in oncology care for selected solid tumors where a multi-targeted tyrosine kinase inhibitor approach is clinically appropriate. In metastatic renal cell carcinoma, sunitinib is part of targeted therapy strategies aimed at slowing disease progression within a structured plan that includes blood pressure monitoring, lab checks, and assessment of side effects. In gastrointestinal stromal tumor, sunitinib may be used after prior therapy when defined by specialist guidance. In pancreatic neuroendocrine tumors, sunitinib can be used in appropriate patients as part of longer-term disease control planning under specialist supervision.

Common Searches and Treatment Contexts for Sunitinib

• Sutent for RCC: Sutent (sunitinib) is used in metastatic renal cell carcinoma as targeted therapy within oncologist-managed care and scheduled monitoring.
• Sunitinib for GIST: Sunitinib is used for gastrointestinal stromal tumor in specific settings, typically after prior therapy, with treatment goals and follow-up defined by a specialist.
• Sunitinib for pNET: Sutent is used in pancreatic neuroendocrine tumors in suitable patients as part of a complete oncology treatment plan.
• VEGFR TKI Targeted Therapy: Sunitinib inhibits signaling pathways involved in tumor angiogenesis, which is why it is classified as a VEGFR-targeted tyrosine kinase inhibitor.
• Buy Sutent Online: Patients with a confirmed prescription and monitoring plan may seek reliable access to original-packaging Sutent to support therapy continuity.

How Sunitinib Works in Chemotherapy

Sunitinib works by inhibiting multiple tyrosine kinases involved in tumor growth and tumor blood vessel development, including receptors related to vascular endothelial growth factor (VEGFR) and platelet-derived growth factor (PDGFR). By reducing signaling that supports angiogenesis, sunitinib can limit the formation of new blood vessels that tumors use for oxygen and nutrient supply. This targeted mechanism differs from classic cytotoxic chemotherapy because it focuses on molecular signaling pathways rather than broadly damaging dividing cells.

Because these pathways also affect normal tissues, monitoring is essential. Blood pressure changes, fatigue, gastrointestinal effects, skin reactions, thyroid changes, and blood count abnormalities can occur. Your oncologist balances expected benefit with safety and may adjust the plan based on symptoms and laboratory results.

Dosage & Administration

Sutent capsules must be taken exactly as prescribed by an oncologist. Sutent dosage is individualized and commonly delivered in planned treatment cycles with scheduled assessment and follow-up, depending on the indication and tolerability. Swallow capsules whole with water and take them on the schedule provided by your clinic. Do not open, crush, or chew capsules unless your care team gives a specific alternative instruction.

Drug interactions can be clinically important, so share a complete list of prescription medicines, over-the-counter products, and supplements with your oncologist and pharmacist. If you miss a dose, follow your clinic’s instructions rather than taking extra capsules to compensate.

Precautions

Sunitinib can raise blood pressure and may increase cardiovascular risk in susceptible patients, which is why blood pressure monitoring and periodic clinical review are important. It can also affect blood counts and thyroid function, and liver tests may be monitored during treatment. Some patients may have higher bleeding risk or wound-healing concerns, so planned procedures should be discussed with the treating team.

Serious complications are uncommon but require urgent medical attention, including significant bleeding, severe shortness of breath, chest pain, severe weakness, fainting, or symptoms of liver injury such as jaundice. Pregnancy should be avoided during therapy, and contraception planning should be discussed with a qualified clinician.

Sunitinib Side Effects

Common side effects

Common sunitinib side effects may include fatigue, diarrhea, nausea, reduced appetite, mouth sores, skin or hair changes, hand-foot skin reactions, and elevated blood pressure. Some patients experience changes in taste or thyroid function. Report persistent or worsening symptoms early so your oncology team can guide supportive care.

Serious side effects

Serious side effects require urgent medical attention and may include major bleeding, severe hypertension complications, heart problems, severe infection, significant liver injury, or severe shortness of breath. If you develop alarming symptoms, seek urgent care and inform clinicians that you are taking sunitinib.

Storage

Store Sutent capsules in original packaging as directed on the label, protected from moisture and excessive heat. Keep out of reach of children. Do not use after the expiry date printed on the carton.

Why Buy from Generic Meds Mart

Generic Meds Mart supports access and logistics for specialty oncology medicines such as Sutent (sunitinib). Products are supplied in original packaging sourced through licensed channels with batch and expiry information for verification by clinics and pharmacies. Pricing is displayed in USD, secure checkout supports straightforward ordering, and discreet outer packaging helps protect privacy.

Worldwide delivery options can help patients coordinate refills with monitoring schedules and specialist visits. Generic Meds Mart does not replace your treating oncologist. All clinical decisions about whether Sutent is appropriate, how long to use it, and how to manage side effects must be made by qualified healthcare professionals.

Order Now

Before ordering Sutent from Generic Meds Mart, you should have a confirmed diagnosis and a treatment plan defined by your oncologist for RCC, GIST, or pNET. Your clinic will confirm the appropriate strength and pack size and set a monitoring plan for blood pressure, labs, and side effects. Once your plan is confirmed, select the correct Sutent strength and pack, add it to your cart, and complete secure checkout in USD.

Do not start, stop, or change sunitinib therapy without specialist supervision. If you develop heavy bleeding, chest pain, severe shortness of breath, jaundice, or rapidly worsening symptoms, seek urgent medical care and inform clinicians that you are receiving sunitinib.

FAQ about Sutent (Sunitinib)

Q1: What is Sutent used for?
Sutent contains sunitinib, a targeted tyrosine kinase inhibitor used in specialist-led plans for metastatic renal cell carcinoma, certain gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors in appropriate patients.

Q2: How are Sutent capsules usually taken?
Sutent is taken by mouth on a schedule defined by an oncologist, often as part of planned treatment cycles with monitoring. Follow your clinic’s instructions and do not change the schedule on your own.

Q3: What monitoring is important during sunitinib therapy?
Monitoring often includes blood pressure checks and periodic lab tests such as blood counts, liver tests, and thyroid function, with frequency defined by your oncology team.

Q4: What should I do if I miss a dose?
Follow your clinic’s instructions and do not take extra doses to make up for a missed dose unless your oncologist specifically advises it. If unsure, contact your prescribing team.

Q5: What are common sunitinib side effects?
Common side effects can include fatigue, diarrhea, nausea, mouth sores, skin changes, hand-foot reactions, and high blood pressure. Report persistent or severe symptoms early for specialist guidance.

Q6: Is sunitinib the same as Sutent (Generic Sutent)?
Sunitinib is Generic Sutent – it contains the same active ingredient (sunitinib) as Sutent. They are used for the same indication at the same strength, but may differ in manufacturer, inactive ingredients (excipients), capsule appearance, and packaging. If you are switching between products, confirm the substitution with a qualified healthcare professional.

Erlonat Erlotinib Tablets 100 mg, 150 mg (1 pack / 30 tabs)

At a Glance

Generic Name: Erlotinib

Brand Name: Erlonat

Strength & Pack Size: 100 mg or 150 mg per tablet; 1 pack / 30 tablets

Dosage Form & Route: Oral tablet, swallowed whole with water

Therapeutic Class: EGFR tyrosine kinase inhibitor (EGFR inhibitor), targeted anticancer therapy

Primary Indication: EGFR mutation-positive non-small cell lung cancer (NSCLC) in adults where erlotinib is appropriate

Usual Adult Dose: Often once daily dosing in specialist regimens, with strength selected by indication and tolerability

Prescription Status: Prescription-only medicine

Storage: Store as directed on the label, protect from moisture and light, keep out of reach of children

Product Description

Erlonat contains erlotinib, an oral EGFR inhibitor used in selected oncology treatment plans for non-small cell lung cancer, including EGFR mutation-positive NSCLC when a specialist determines it is appropriate. Erlonat is supplied as erlotinib tablets in 100 mg and 150 mg strengths, typically as 1 pack / 30 tabs, to support ongoing therapy and monitoring. Patients and caregivers managing a prescription-led lung cancer plan often look to buy erlotinib online as part of continuity planning, especially when the correct strength and pack size must match a specialist schedule. Erlotinib is a prescription-only anticancer medicine and should only be used within a confirmed diagnosis and an oncologist-led treatment plan.

In EGFR-positive lung cancer care, treatment decisions are individualized. Your oncology team considers EGFR test results, prior therapies, liver function, skin tolerance, gastrointestinal side effects, lung symptoms, and potential drug interactions before prescribing an EGFR-targeted therapy. Erlonat may be selected as Generic Tarceva in treatment pathways where erlotinib-based therapy fits local guidance and patient needs. Do not start, stop, or change dosing without medical supervision, and do not substitute professional advice with self-directed adjustments.

Generic Meds Mart supplies Erlonat erlotinib tablets in original manufacturer packaging sourced through licensed channels. The pack typically displays the product name, strength, active ingredient, batch number, and expiry date so your clinic or pharmacist can verify the medicine on receipt. Orders are shipped in discreet outer packaging to support privacy, and worldwide delivery options help patients coordinate refills with monitoring appointments.

Key Uses

Erlonat (erlotinib tablets) is used in adults with NSCLC when EGFR inhibition is clinically appropriate, including EGFR mutation-positive NSCLC under specialist care. In this setting, erlotinib targets EGFR signaling that can drive tumor growth in a defined subset of patients, and treatment is planned alongside regular follow-up.

In some oncology pathways, erlotinib may also be used with other anticancer medicines in specialist-defined treatment plans, based on clinical guidelines, prior therapy exposure, and tolerability. Your oncologist defines the goals of therapy, how response is measured, and what monitoring is required. If you are comparing erlotinib price options or planning to order Erlonat online, confirm the exact strength and pack size with your clinic before purchase.

Common Searches and Treatment Contexts for Erlotinib

Generic Tarceva (Erlotinib): Erlonat is a therapeutically equivalent generic version of the brand-name drug Tarceva, containing the same active ingredient (erlotinib) for specialist-led NSCLC care.

EGFR Inhibitor for NSCLC: Erlotinib is an EGFR tyrosine kinase inhibitor used in defined non-small cell lung cancer settings, including EGFR mutation-positive disease when prescribed by an oncologist.

Erlotinib 150 mg Tablets: This strength is commonly used in once daily regimens for NSCLC in appropriate patients, with monitoring and dose adjustments guided by tolerability.

Erlotinib 100 mg Tablets: This strength may be used in specialist regimens when clinically appropriate, including situations where dose selection is guided by indication, interactions, or side effect management.

Buy Erlotinib Online: Patients with a confirmed prescription and oncology plan can seek reliable access to original-packaging erlotinib tablets to maintain therapy continuity.

How Erlotinib Works in Chemotherapy

Erlotinib works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase. In certain cancers, EGFR signaling can support cell growth and survival. By blocking EGFR activity, erlotinib can reduce downstream signaling that tumor cells rely on, which can help control disease in appropriate patients when therapy is taken consistently as prescribed.

Because erlotinib is targeted therapy rather than classic cytotoxic chemotherapy, its side effect profile differs from many infusion chemotherapies, but monitoring is still essential. Common issues include skin rash and diarrhea, and serious risks can include lung inflammation, liver injury, and other complications depending on individual factors and interacting medicines. Your specialist balances expected benefit with safety and may modify the plan based on lab results and symptoms.

Dosage & Administration

Erlonat tablets are taken by mouth exactly as prescribed by your oncologist. Erlonat dosage selection is individualized, and the chosen strength (100 mg or 150 mg) depends on your indication, treatment history, interactions, and tolerability. Swallow tablets whole with water. Do not split, crush, or chew tablets unless your clinic provides specific instructions.

Drug interactions can be clinically important. Always share a complete list of prescription medicines, over-the-counter products, and supplements with your oncology team. If you miss a dose, follow your clinic’s guidance rather than taking extra tablets to compensate. If you are unsure about timing with food or other medicines, ask your specialist or pharmacist.

Precautions

Before starting erlotinib, your specialist will review your medical history and baseline tests. It is important to mention liver disease, prior lung problems, severe skin conditions, eye symptoms, and any gastrointestinal disorders. Report new or worsening shortness of breath, persistent cough, chest discomfort, severe diarrhea, dehydration symptoms, or yellowing of the skin or eyes promptly.

Skin reactions can be significant, and your team may recommend supportive skin care and monitoring. Erlotinib can also interact with other medicines, so do not introduce new supplements without discussing them with your oncology team. Pregnancy planning should be discussed with a specialist, and breastfeeding guidance should follow medical advice based on your clinical situation.

Erlotinib Side Effects

Common side effects

Common erlotinib side effects may include acne-like rash, dry skin, itching, diarrhea, nausea, decreased appetite, fatigue, and mouth irritation. Many effects can be managed within a specialist-led plan, but persistent or worsening symptoms should be discussed with your treating team rather than managed by changing the dose independently.

Serious side effects

Serious side effects require urgent medical attention and may include severe or persistent diarrhea with dehydration, severe skin reactions, eye pain or vision changes, clinically significant liver injury, and lung inflammation that can present as worsening shortness of breath or cough. If you develop sudden breathing problems, severe weakness, confusion, fainting, jaundice, or rapidly worsening symptoms, seek urgent care and tell clinicians you are receiving erlotinib.

Storage

Store Erlonat as directed on the label, in the original packaging, protected from moisture and heat. Keep out of reach of children. Do not use after the expiry date printed on the pack. Keep tablets in their original blister until use to reduce mix-ups and preserve verification details.

Why Buy from Generic Meds Mart

Generic Meds Mart supports access and logistics for specialty oncology medicines such as Erlonat erlotinib tablets. Products are supplied in original packaging from licensed channels with batch and expiry information to support verification by clinics and pharmacies. Orders are processed via secure checkout in USD, and shipments are packed in discreet outer cartons.

For patients coordinating targeted therapy refills, worldwide delivery and tracking can help align supply with specialist appointments and monitoring schedules. Generic Meds Mart does not replace your treating doctor. Decisions about whether erlotinib is appropriate, how long to use it, and how side effects are managed must be made by qualified healthcare professionals.

Order Now

Before you order Erlonat from Generic Meds Mart, you should have a confirmed NSCLC diagnosis and a treatment plan agreed with your oncologist, including which strength is needed and how monitoring will be handled. Your clinic will advise what tests are needed and how often. Once your plan is confirmed, select Erlonat 100 mg or Erlonat 150 mg (1 pack / 30 tabs), add it to your cart, and complete secure checkout in USD.

Do not start therapy on your own, and do not stop or change dosing without medical guidance. If you develop severe diarrhea, worsening breathing symptoms, jaundice, or other urgent symptoms, seek medical care and inform clinicians that you are taking erlotinib.

FAQ about Erlonat (Erlotinib)

Q1: What is Erlonat used for?
Erlonat contains erlotinib, an EGFR inhibitor used in adults with non-small cell lung cancer in specialist-defined settings, including EGFR mutation-positive NSCLC when prescribed as part of an oncology treatment plan.

Q2: What is the difference between Erlonat 100 mg and Erlonat 150 mg?
Both strengths contain the same active ingredient (erlotinib). Your oncologist selects 100 mg or 150 mg based on your indication, interactions, tolerability, and monitoring results.

Q3: Can I buy Erlonat online if I already have a prescription?
Yes. Patients with a confirmed prescription and oncology plan often order erlotinib tablets online to maintain therapy continuity. Confirm the correct strength and pack size with your clinic before ordering.

Q4: What monitoring is usually needed during erlotinib therapy?
Monitoring may include clinical checks for rash and diarrhea, assessment of lung symptoms, and laboratory monitoring such as liver function tests, with frequency defined by your oncology team.

Q5: What should I do if I miss a dose?
If you miss a dose, follow your clinic’s instructions and do not take extra tablets to compensate unless your specialist tells you to. If you are unsure, contact your prescribing team for guidance.

Q6: Is Erlonat 100 mg or 150 mg the same as Tarceva (Generic Tarceva)?
Erlonat 100 mg and Erlonat 150 mg are Generic Tarceva – they contain the same active ingredient (erlotinib) as Tarceva. They are used for the same indication at the same strength, but may differ in manufacturer, inactive ingredients (excipients), tablet appearance, and packaging. If you are switching between products, confirm the substitution with a qualified healthcare professional.

Erlocip Erlotinib – 150 mg (1 pack / 30 tablets)

At a Glance

Brand name: Erlocip

Generic name: Erlotinib hydrochloride

Active ingredient: Erlotinib

Strength & pack size: Erlocip 150 mg (1 pack / 30 tablets)

Dosage form: Oral film-coated tablets

Main indication: Advanced or metastatic non–small cell lung cancer (NSCLC) and selected pancreatic cancer indications

Therapeutic class: EGFR tyrosine kinase inhibitor

Use in therapy: Targeted first-line or subsequent EGFR-directed therapy in NSCLC and other approved settings

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Erlocip 150 mg tablets are a generic erlotinib hydrochloride medicine used as targeted therapy for certain advanced cancers.
Erlotinib is an EGFR tyrosine kinase inhibitor (TKI) that interferes with signalling pathways driving tumour growth,
particularly in advanced non–small cell lung cancer (NSCLC).
Erlocip 150 mg (1 pack / 30 tablets) provides a convenient once-daily strength of erlotinib for patients whose oncologists have recommended EGFR-directed treatment.

Erlocip erlotinib tablets are often used in locally advanced or metastatic NSCLC, especially when tumours harbour activating
EGFR mutations that make them sensitive to EGFR tyrosine kinase inhibition. In some settings,
erlotinib tablets may also be used in pancreatic cancer, according to recognised protocols and specialist judgement.
Because Erlocip is a generic erlotinib product, it contains the same active ingredient as branded erlotinib while offering more accessible pricing in USD.

Each Erlocip 150 mg tablet contains erlotinib hydrochloride equivalent to 150 mg of erlotinib.
Tablets are taken by mouth, usually once daily, and your oncologist may instruct you to take Erlocip on an empty stomach or to avoid certain foods and medicines that alter absorption.
When you buy Erlocip 150 mg online from Generic Meds Mart, you receive medicines from licensed manufacturers and authorised distributors operating under recognised GMP standards.
Discreet outer packaging protects your privacy, while original blisters and cartons preserve full product information.

This Erlocip 150 mg (1 pack / 30 tablets) product is intended only for patients already under specialist oncology care who have been advised to use
erlotinib therapy. Generic Meds Mart does not diagnose cancer or change treatment plans;
the information on this page supports informed discussions with your oncology team about access to generic erlotinib tablets.

Key Uses

Erlocip 150 mg erlotinib tablets are typically used for the following indications under specialist supervision:

• Treatment of locally advanced or metastatic non–small cell lung cancer (NSCLC), especially in EGFR mutation–positive tumours
• First-line, maintenance or subsequent therapy in selected NSCLC patients where EGFR TKI treatment is recommended
• Treatment of certain advanced pancreatic cancer cases, in combination with other agents, where erlotinib is indicated

Your oncologist will determine whether Erlocip 150 mg is appropriate, specify the daily dose and decide how long
erlotinib treatment should continue.

How Erlotinib Works in Chemotherapy

Erlotinib is a targeted anticancer agent often grouped within modern systemic chemotherapy and targeted therapy regimens.
Erlocip contains erlotinib, an EGFR tyrosine kinase inhibitor (TKI) that blocks signalling from the epidermal growth factor receptor.
In many NSCLC tumours, activating EGFR mutations cause continuous signalling and uncontrolled cell growth.

Erlocip erlotinib tablets bind to the intracellular tyrosine kinase domain of EGFR and block ATP binding,
disrupting downstream signalling pathways that promote cancer cell proliferation and survival. In tumours that depend heavily on EGFR signalling,
this can lead to tumour shrinkage or stabilisation. Because erlotinib targets a molecular driver of the cancer rather than all rapidly dividing cells,
its side effect profile differs from traditional cytotoxic chemotherapy, but careful monitoring is still required.

EGFR mutation testing is an important part of deciding whether Erlocip erlotinib is appropriate.
Your oncologist will interpret test results and determine whether an EGFR TKI such as Erlocip fits your overall treatment plan.

Dosage & Administration

Erlocip 150 mg erlotinib tablets must always be taken exactly as prescribed by your oncologist.
Daily dosing, timing and duration of therapy depend on your diagnosis, tumour characteristics, other medicines and response to treatment.

• Take Erlocip tablets by mouth with water; your doctor may instruct you to take them on an empty stomach or at specific times relative to meals.
• Swallow erlotinib tablets whole without crushing, splitting or chewing unless your doctor or pharmacist provides specific instructions.
• Take Erlocip 150 mg once daily at approximately the same time each day, unless your oncologist advises otherwise.
• Do not change your dose, skip doses or stop taking Erlocip without clear guidance from your oncology team.
• If you miss a dose, follow your doctor’s instructions; do not double the next dose unless specifically advised.

Your oncologist will schedule regular visits, blood tests and imaging studies to monitor your response to
Erlocip erlotinib therapy and to adjust the treatment plan if necessary.

Precautions

Before starting Erlocip 150 mg, inform your doctor about your full medical history and all medicines, supplements or herbal products you use. Important considerations include:

• History of lung diseases such as interstitial lung disease, pulmonary fibrosis or other chronic lung conditions
• Liver disease, kidney impairment or significant cardiovascular disease
• Previous severe skin reactions or serious gastrointestinal problems
• Use of medicines that alter stomach acidity (proton pump inhibitors, H2 blockers, antacids)
• Use of CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with erlotinib
• Use of anticoagulants, especially warfarin, which may require closer monitoring during Erlocip erlotinib therapy

Erlotinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Erlocip. Your oncology team will explain which precautions and monitoring tests apply to you.

Erlotinib Side Effects

Common side effects

Many patients experience side effects when starting Erlocip erlotinib tablets, especially during the first weeks of therapy. Common side effects may include:

• Acne-like skin rash, often on the face, scalp or upper trunk
• Dry, itchy or sensitive skin, sometimes with increased sun sensitivity
• Diarrhea or loose stools
• Mild nausea, vomiting or stomach discomfort
• Reduced appetite and weight loss
• Fatigue or general weakness

These effects are often manageable with supportive care, skin protection, diet adjustments or dose modifications.
You should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of erlotinib are less common but serious and require urgent medical attention. Serious reactions may include:

• New or worsening shortness of breath, cough or fever that may indicate interstitial lung disease or severe lung inflammation
• Severe or persistent diarrhea with signs of dehydration, such as dizziness, fainting or reduced urine output
• Severe abdominal pain, black or bloody stools or vomiting blood, which may indicate gastrointestinal perforation or bleeding
• Signs of liver problems, including yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Severe skin reactions with widespread rash, blistering, peeling or involvement of the mouth, eyes or other mucous membranes

If you experience any of these serious symptoms while taking Erlocip 150 mg, seek immediate medical care and contact your oncology team as soon as possible.

Storage

• Store Erlocip 150 mg tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the tablets in their original blisters and carton until use to protect them from moisture and light.
• Keep erlotinib tablets out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired Erlocip erlotinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Erlocip 150 mg erlotinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Erlocip 150 mg online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic erlotinib tablets compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your oncologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.

Order Now

Erlocip 150 mg erlotinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of an oncologist.
Before you order Erlocip 150 mg online, ensure that you have a valid prescription or written treatment plan specifying erlotinib, the 150 mg strength and the intended duration of therapy.

Select Erlocip 150 mg (1 pack / 30 tablets), choose the appropriate quantity, add Erlocip to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.

Q6: Is Erlocip 150 mg the same as Tarceva (Generic Tarceva)?
Erlocip 150 mg is Generic Tarceva — it contains the same active ingredient (erlotinib) as Tarceva. It’s used for the same purpose at the same strength, while differences may be in manufacturer, inactive ingredients (excipients), tablet appearance, and packaging. If you’re switching between products, confirm the substitution with a qualified healthcare professional.